VXUS Has Delivered Better Returns Than IEFA Over the Past 5 Years. Should It Be in Your Portfolio?

Vanguard Total International Stock ETF (VXUS) has returned 11.5% year to date in 2026, ahead of the iShares Core MSCI EAFE ETF (IEFA) at 7.9%, and it now leads on trailing 1-, 3-, 5-, and 10-year performance. The article argues VXUS is preferable because it offers broader exposure, including 27% in emerging markets and 8% in Canada, versus IEFA’s developed-market-only mandate. The piece is opinionated portfolio commentary rather than a catalyst-driven market event, so direct price impact is likely limited.

Analysis

The real signal here is not “international is better,” but that the market is rewarding breadth plus sector dispersion. The broader ex-US basket is getting paid for owning more AI-adjacent supply chain exposure in Asia and more emerging-market beta, while the developed-only basket remains more levered to slow-growth Europe and defensives. That creates a second-order winner set: semi-tooling, memory, and AI hardware ecosystem names benefit disproportionately from any further rerating of global capex outside the U.S., whereas banks and pharma mostly act as ballast.

The underappreciated catalyst is currency. A weaker dollar or a flattening in U.S. real-rate outperformance would mechanically improve translated returns for both funds, but the broader fund has more torque because a larger share of its earnings base is in higher-beta currencies and EM revenues. Conversely, if risk aversion spikes on geopolitics or oil, the broader basket can underperform quickly because Taiwan/Korea/China exposure is the first place global allocators de-risk, even if long-run fundamentals remain intact.

Consensus is likely overestimating the durability of recent relative outperformance. The narrow developed-market ETF has a cleaner factor profile and less embedded geopolitical headline risk, so in a 3-6 month window it can outperform on a “quality + yield + defense” regime. But over 12-24 months the broader ETF should keep the edge unless U.S. growth re-accelerates sharply or EM policy/FX deteriorates meaningfully. The key mistake would be treating this as a simple geography call rather than a bet on global capex, dollar direction, and Asia supply-chain risk premia.

Key Decisions for Investors

• Go long VXUS vs short IEFA in a 6-12 month relative-value pair; thesis is broader tech/EM participation plus dollar sensitivity, with stop-loss if global risk-off drives Asia de-risking.
• For lower beta international exposure, keep IEFA as the defensive leg and fund it by trimming U.S. mega-cap growth; this is the cleaner hedge if geopolitical headlines intensify over the next 1-3 months.
• Add ASML as a standalone long on any 5-8% pullback; it is the highest-quality leverage to non-U.S. semiconductor capex and should outperform both ETFs on any re-acceleration in AI spend over 6-18 months.
• Use TSM as a tactical buy only if Taiwan risk premium compresses; upside is strongest in a benign geopolitics window, but it is the most vulnerable name in the broader basket during sudden risk-off episodes.
• If maintaining a portfolio-level hedge, pair a modest VXUS overweight with dollar strength protection; the trade works best if USD momentum reverses, but can give back quickly if the Fed stays hawkish relative to peers.